Noevir Holdings Co (TSE:4928) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4928 Noevir Holdings Co Ltd TSE:4928
88 GF Score
Price 円4,830.00
GF Value 円4,974.20
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Noevir Holdings Co Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Noevir Holdings Co is: Low Risk: Strong fundamentals, worth long-term holding.

Noevir Holdings Co  (TSE:4928) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Noevir Holdings Co Risk Assessment Related Terms

TSE:4928 vs PG, CL, KVUE: Risk Assessment Comparison

For the Household & Personal Products subindustry, Noevir Holdings Co's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Noevir Holdings Co Risk Assessment vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Noevir Holdings Co's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Noevir Holdings Co's Risk Assessment falls into.


TSE:4928
88GF Score
Noevir Holdings Co Ltd TSE:4928
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Noevir Holdings Co (TSE:4928) Overvalued in 2026?

Based on GuruFocus' analysis, Noevir Holdings Co stock appears to be undervalued. The current stock price of 円4,830.00 is trading 2.9% below its estimated GF Value™ of 円4,974.20. GuruFocus considers Noevir Holdings Co to be Fairly Valued.

Key valuation signals for TSE:4928:

  • Risk Assessment:
  • GF Value™: 円4,974.20 vs. price of 円4,830.00 (2.9% below fair value)
  • GF Score™: 88/100 with 2 warning signs

No single metric tells the full story. See the TSE:4928 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Noevir Holdings Co Business Description

Address 13-1, Minatojima Nakamachi 6-chome, Chuo-ku, Kobe, JPN, 650-8521
Noevir Holdings Co Ltd is a Japan-based company that is principally engaged in two businesses: cosmetics and pharmaceuticals and health food. The cosmetics business produces and offers skincare and makeup products under a number of brands, like Noevir, NOV, and Sana. The pharmaceuticals and health food business develops, produces, and sells a broad range-of-products, including Nanten Nodo Ame cough drops, functional drinks, and other over-the-counter pharmaceuticals, such as cold remedies and eye drops, and health food products as well. These two businesses jointly contribute the majority of the company's revenue. The company also operates apparel and aircraft sales and leasing. The company has a presence in many countries across the world and focuses on developing Asian markets.
88GF Score

Get the complete analysis for TSE:4928

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円4,830.00
Price
円4,974.20
GF Value